Enovis Corp

ENOV

32.150USD

+0.570+1.80%

Market hours （ET）Quotes delayed by 15 min

Score

Industry at a Glance

Industry Ranking

54 / 208

Overall Ranking

170 / 4730

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 11 analysts

Buy

Current Rating

54.333

Target Price

+78.38%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 34.84% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 6110.46.

Overvalued

The company’s latest PE is -2.04, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 62.33M shares, decreasing 12.84% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 6.37M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.36.

The company's current financial score is 6.69, which is lower than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 558.83M, representing a year-over-year increase of 8.25%, while its net profit experienced a year-over-year increase of 22.27%.

Score

Industry at a Glance

Previous score

6.69

Change

0



Financials

5.88

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.47

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.22

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.14

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

6.75

Key Metrics

Free cash flow

No Data

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is -2.08, which is -0.48% below the recent high of -2.07 and -8.73% above the recent low of -2.26.

Score

Industry at a Glance

Previous score

2.00

Change

-0.8

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 54/208

No Data

The company’s current earnings forecast score is 8.36, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Enovis Corp is 55.00, with a high of 75.00 and a low of 41.00.

Score

Industry at a Glance

Previous score

8.36

Change

0

Support & Resistance

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The company’s current price momentum score is 9.03, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 33.55 and the support level at 26.98, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.18

Change

-0.18

Support & Resistance

No Data

Institutional Confidence

Currency: USD Updated：2025-09-10

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 109.11%, representing a quarter-over-quarter decrease of 8.87%. The largest institutional shareholder is The Vanguard, holding a total of 6.37M shares, representing 11.14% of shares outstanding, with 13.88% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

6.52M

+34.39%

The Vanguard Group, Inc.

Star Investors

6.08M

-0.12%

American Century Investment Management, Inc.

3.52M

+11.71%

Dimensional Fund Advisors, L.P.

2.93M

+0.96%

Davenport Asset Management

3.07M

-6.31%

State Street Global Advisors (US)

1.89M

+9.37%

Royce Investment Partners

Star Investors

2.49M

+0.82%

Hood River Capital Management LLC

1.44M

+118.10%

River Road Asset Management, LLC

1.39M

+12.40%



1

2



The company's beta value is 1.47. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Enovis Corp

ENOV

6.27 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Insulet Corp

PODD

7.89 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Stevanato Group SpA

STVN

7.59 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Penumbra Inc

PEN

7.34 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

iRhythm Technologies Inc

IRTC

7.31 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Merit Medical Systems Inc

MMSI

7.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.